If you've recently received a diagnosis of type 2 diabetes, understanding your treatment options is an important first step.

Amycretin, an oral weight loss drug, led to up to 13% body weight reduction in three months, showing potential for continued ...

SAN FRANCISCO and SUZHOU, China, Sept. 11, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

"There are solutions, so when Novolin 70/30 is out of stock, there are other options that the patient can use to take care of their diabetes ... about their treatment plan to determine the ...

The weight-loss drug liraglutide (Saxenda) helped obese children lower their BMI and reach a healthier weight, researchers ...

Industry professionals attend conferences to network, learn, connect with peers and, now, thanks to smartphone-based ...

Amycretin, a dual pathway, oral weight loss drug, was found to be safe and tolerable in a phase 1 study and led to weight loss of up to 13% in people with overweight and obesity.

For regulatory purposes, the study design would only test each new treatment against the control ... investigators at pediatric diabetes research centers, and regulatory agencies.

Individuals who received a once-a-day oral weight loss drug lost up to 13% of their body weight over three months, the annual meeting of the European Association for the Study of Diabetes (EASD) in ...

Whether we’re craving salt, sugar, a cold beer or a perfectly cooked steak, every guy knows how to satisfy his own cravings.

More plaintiffs are continuing to join the diabetes drug Ozempic lawsuits against Novo Nordisk; and, until a couple of weeks ...